Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
Latest Information Update: 14 Dec 2015
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
Most Recent Events
- 14 Dec 2015 New trial record